LONDON — German scientists have found a new genetic basis for why some patients respond better to the anti-clotting medicine Plavix, which could be used to test people before they get the world’s second-biggest drug.
LONDON — German scientists have found a new genetic basis for why some patients respond better to the anti-clotting medicine Plavix, which could be used to test people before they get the world’s second-biggest drug.
